NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Código da empresaNEO
Nome da EmpresaNeogenomics Inc
Data de listagemDec 10, 2012
Fundado em1998
CEOMr. Antony P. Zook
Número de funcionários2200
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 10
Endereço9490 Neogenomics Way
CidadeFORT MYERS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33912
Telefone12397680600
Sitehttps://neogenomics.com/
Código da empresaNEO
Data de listagemDec 10, 2012
Fundado em1998
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados